Safety, Tolerability, and Pharmacokinetic Parameters of Increasing Doses of Ingavirin Forte, Capsules, During Single and Subsequent Multiple Oral Administration in Healthy Volunteers (clinicaltrials.gov) - Mar 5, 2025 - P1 | N=36 | Recruiting | Sponsor: Valenta Pharm JSC
New P1 trial • Infectious Disease • Influenza • Respiratory Diseases
|